Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. United States
  4. Nasdaq
  5. Clarus Corporation
  6. Summary
    CLAR   US18270P1093

CLARUS CORPORATION

(CLAR)
  Report
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
09/22/2021 09/23/2021 09/24/2021 09/27/2021 09/28/2021 Date
26.65(c) 27.29(c) 27.53(c) 27.7(c) 26.92 Last
67 199 61 373 77 885 96 061 103 170 Volume
+0.72% +2.40% +0.88% +0.62% -2.82% Change
More quotes
Estimated financial data (e) (USD)
Sales 2021 351 M - -
Net income 2021 22,8 M - -
Net Debt 2021 189 M - -
P/E ratio 2021 40,3x
Yield 2021 0,37%
Sales 2022 432 M - -
Net income 2022 37,0 M - -
Net Debt 2022 147 M - -
P/E ratio 2022 25,8x
Yield 2022 0,37%
Capitalization 910 M 910 M -
EV / Sales 2021 3,13x
EV / Sales 2022 2,45x
Nbr of Employees 600
Free-Float 58,2%
More Financials
Company
Clarus Corporation (Clarus) is focused on the outdoor and consumer industries. Its primary business is designing, developing, manufacturing and distributing of outdoor equipment and lifestyle products focused on the climb, ski, mountain, sport and skincare markets. The Company's brands include the Black Diamond, Sierra, Barnes, PIEPS, SKINourishment and Rhino-Rack through outdoor specialty and online retailers,... 
More about the company
Ratings of Clarus Corporation
Trading Rating : 
Investor Rating : 
ESG Refinitiv : 
C
More Ratings
All news about CLARUS CORPORATION
09:55aLIPOCINE : Resubmitted New-Drug Application for Tlando Affirmed by FDA
MT
09/20CLARUS THERAPEUTICS : Oppenheimer Initiates Coverage on Clarus Therapeutics Holdings With ..
MT
09/20CLARUS THERAPEUTICS : Cantor Fitzgerald Starts Clarus Therapeutics at Overweight With $20 ..
MT
09/16CLARUS : Financial Statements and Exhibits (form 8-K/A)
AQ
09/16CLARUS THERAPEUTICS : Working With McGill University to Develop Technology for Rare Diseas..
MT
09/16DEUTSCHE BÖRSE : Financial industry urges EU to extend euro swaps clearing in London
RE
09/09Clarus Therapeutics, Blue Water Acquisition Complete Merger
MT
08/30CLARUS : Sets September 2021 Virtual Conference Schedule
PU
08/27SECTOR UPDATE : Health Care Stock Fading Near Friday Close
MT
08/27BLUE WATER ACQUISITION : Shareholders OK Merger With Clarus Therapeutics
MT
08/09EQS-NAV : Net Asset Value as of July 31, 2021
DJ
08/03CLARUS : Exane BNP Paribas Adjusts Clarus PT to $30 From $21, Maintains Neutral Rating
MT
08/03CLARUS : Stifel Nicolaus Adjusts Clarus PT to $35 From $27, Maintains Buy Rating
MT
08/03CLARUS : Roth Capital Adjusts Clarus PT to $35 From $30, Maintains Buy Rating
MT
08/03CLARUS : Jefferies & Co Adjusts Clarus PT to $37 From $30, Maintains Buy Rating
MT
More news
News in other languages on CLARUS CORPORATION
09:55aLa FDA confirme la nouvelle demande d'autorisation de mise sur le marché de Tlando prés..
09/16Clarus Therapeutics travaille avec l'Université McGill pour développer une technologie ..
09/13TORQ RESOURCES INC. : Torq ernennt Carolina Vargas und Marie-Hélène Turgeon zu Direktoren
09/09Clarus Therapeutics et Blue Water Acquisition concluent leur fusion
08/09EQS-NAV : Net Asset Value per 31. Juli 2021
More news
Analyst Recommendations on CLARUS CORPORATION
More recommendations
Chart CLARUS CORPORATION
Duration : Period :
Clarus Corporation Technical Analysis Chart | CLAR | US18270P1093 | MarketScreener
Technical analysis trends CLARUS CORPORATION
Short TermMid-TermLong Term
TrendsNeutralBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 7
Last Close Price 26,92 $
Average target price 34,67 $
Spread / Average Target 28,8%
EPS Revisions
Managers and Directors
John Christian Walbrecht President
Aaron J. Kuehne Chief Financial Officer, Secretary & Treasurer
Warren Beatty Kanders Executive Chairman
Michael A. Henning Independent Director
Donald L. House Independent Director
Sector and Competitors
1st jan.Capi. (M$)
CLARUS CORPORATION79.87%936
PELOTON INTERACTIVE, INC.-39.32%27 667
CALLAWAY GOLF COMPANY25.32%5 596
ASICS CORPORATION35.86%4 482
ACUSHNET HOLDINGS CORP.23.29%3 694
MIPS AB (PUBL)72.43%2 671